Join us at this upcoming meeting, which will update healthcare professionals on lipid management for better patient care. The symposium will address the use of new and emerging therapies in difficult management decisions in this field, providing participants with a unique opportunity to learn about the progress in this field in recent years.
Via live talks delivered by experts in the field, event participants will receive updates on modern approaches to lipid management, addressing established and emerging therapies in this field.
This meeting will also be available as an on-demand recording. Register to watch on demand.
Benefits of attending:
Follow us on:
Facebook
Instagram
LinkedIn
Twitter
YouTube
We would like to thank our sponsors Amarin, Daiichi Sankyo, Novartis and Pfizer for their support of this meeting.
Please note that the main scientific programme and content has not been influenced in any way by the sponsors.
Dr Abdul Lakdhar, President Elect, Endocrinology and Diabetes Section, Royal Society of Medicine
Chairs: Dr Stella George, President, Endocrinology and Diabetes Section, Royal Society of Medicine and Dr Abdul Lakhdar, President Elect, Endocrinology and Diabetes Section, Royal Society of Medicine
Dr Fizzah Choudry, Consultant in Interventional Cardiology, St Bartholomews Health NHS Trust
Dr Mahtab Sharifi, Consultant Metabolic Physician and Chemical Pathologist, St George's University Hospitals NHS Foundation Trust
Professor Devaki Nair, Consultant Chemical Pathologist and Clinical Lead for Clinical Biochemistry, Royal Free Hospital
Dr Tina Khan, Consultant Cardiologist in Preventive Cardiology and Cardiovascular Magnetic Resonance Imaging, Royal Brompton and Harefield Hospital
A stepwise approach to lipid management - what more can specialist services do to support primary care?
Dr Adie Viljoen, Consultant Chemical Pathologist Physician, East and North Hertfordshire NHS Trust, Honorary Consultant, Cambridge Universities NHS Trust
15 minutes
Combination Therapy – how can injectable siRNA help patients achieve LDL targets in secondary prevention when statins alone are not enough?
Dr Peter Carey, Consultant in Diabetes & Endocrinology, South Tyneside and Sunderland NHS Foundation Trust
15 minutes
Chairs: Dr Stella George, President, Endocrinology and Diabetes Section, Royal Society of Medicine and Dr Abdul Lakhdar, President Elect, Endocrinology and Diabetes Section, Royal Society of Medicine
Dr Kate Shipman, Consultant Chemical Pathologist, University Hospitals Sussex, St Richard’s Hospital
Dr Kate Shipman, Consultant Chemical Pathologist, University Hospitals Sussex, St Richard’s Hospital
Mr Paul Wright, Lead Cardiac Pharmacist, Barts Health NHS Trust
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Registration for this event will close at 1:00am on Monday 18 September 2023. Late registrations will not be accepted.
The agenda is subject to change at any time
If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM’s discretion.
All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.
This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.
